AYŞE BURUŞ | AVESİS

Yayın Ağı

Makaleler 13

1. Clinical and early biochemical responses to botulinum toxin type-A in refractory masticatory myofascial pain: a pilot single-arm study

Meral S. E., Buruş A., Karahan S., Bayrakçı N., Bayazıt Y.

BMC ORAL HEALTH , ss.1-29, 2026 (SCI-Expanded, Scopus)

2. Oral Health Status and Salivary Pepsin Levels in Children With Gastroesophageal Reflux Disease Surgery: A Postoperative Evaluation

SAĞ K., BURUŞ A., ÖZŞİN ÖZLER C., SOYER T., BAYAZIT Y., BOYBEYİ Ö., et al.

International Journal of Clinical Pediatrics , cilt.15, 2026 (Scopus)

3. Investigation of the inhibitory effects of the telomere-targeted compounds on glutathione S-transferase P1.

Ozcan M., Burus A., Mender I., Dikmen Z. G., Gryaznov S. M., Bastug T., et al.

Naunyn-Schmiedeberg's archives of pharmacology , cilt.398, ss.10169-10177, 2025 (SCI-Expanded, Scopus)

4. Mucosal Wetness, Hyposalivation, and Local Defense in Periodontal Inflammation

Acar B., Özcan M., Toz H., Koç N., Sevimli B. S., Berberoglu B., et al.

ORAL DISEASES , cilt.31, ss.2551-2563, 2025 (SCI-Expanded, Scopus)

5. The effect of the combination therapy with chlorophyllin, a glutathione transferase P1-1 inhibitor, and docetaxel on triple-negative breast cancer invasion and metastasis in vivo/in vitro

Buruş A., Ozcan M., Canpinar H., Bozdemir O., Zeybek N. D., Bayazit Y.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY , cilt.398, ss.10569-10580, 2025 (SCI-Expanded, Scopus)

6. Genetic heterogeneity and metabolic reprogramming in breast cancer

DOLAŞ Y., BURUŞ A., ÇELTİKÇİ B.

Acta Medica , cilt.55, sa.4, ss.1-20, 2024 (TRDizin)

7. Effects of Photobiomodulation Application on Glutathione-Related Antioxidant Defense System in Rabbit Eye Tissues

Ozcan M., Buruş A., Boynuyogun E., Calis M., Ozgur F., Bayazit Y.

JOURNAL OF BIOPHOTONICS , cilt.17, sa.10, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. Cross Talk Between Genetics and Biochemistry in The Pathogenesis of Hepatocellular Carcinoma

ÜÇDAL M. T., BURUŞ A., ÇELTİKÇİ B.

Hepatology forum , cilt.5, sa.3, ss.150-160, 2024 (ESCI, Scopus, TRDizin)

9. The effect of genetics and biochemistry on the pathogenesis of cholangiocarcinoma

ÜÇDAL M. T., BURUŞ A., ÇELTİKÇİ B.

INTERNATIONAL JOURNAL OF HEPATOBILIARY AND PANCREATIC DISEASES , cilt.14, sa.2, ss.1-14, 2024 (ESCI)

10. A novel brick on the wall of non-alcoholic fatty liver disease (NAFLD): Nuclear receptor coactivator 4 (NCOA4)

Üçdal M. T., Burus A., Celtikci B., Yasemin Balaban H. Y.

MEDICAL HYPOTHESES , cilt.181, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. Effect of coadministration of antioxidant chlorophyllin with docetaxel on invasion and metastasis in triple-negative breast cancer in vivo/in vitro

Buruş A., Ozcan M., Canpinar H., Bozdemir O., Zeybek N., Bayazit Y.

ANNALS OF ONCOLOGY , cilt.34, ss.201, 2023 (SCI-Expanded, Scopus)

12. Stem Cell and Oxidative Stress-Inflammation Cycle.

Buzoglu H., Buruş A., Bayazıt Y., Goldberg M.

CURRENT STEM CELL RESEARCH AND THERAPY , cilt.18, ss.641-652, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. The Inflammatory Processes Driven by Gut Microbiota

Buruş A., Çeltikçi B., Aksoy Y.

Acta Medica , cilt.52, sa.3, ss.171-179, 2021 (TRDizin)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 6

1. Evaluation of the molecular basis of autoimmune cholestatic liver diseases via serum cytokine release

RADGOHAR A., BURUŞ A., ÜÇDAL M. T., YALÇINKAYA A., BALABAN H. Y., ÇELTİKÇİ B.

49th FEBS Congress, 05 Temmuz 2025, (Özet Bildiri)

2. Radgohar, A; Burus, A; Ucdal, M; Yalcinkaya, A; Balaban, Y; Celtikci, B. Evaluation of the molecular basis of autoimmune cholestatic liver diseases via serum cytokine release. FEBS OPEN BIO. 2025; 15 (Supp2), 450-451Meeting Abstract LB-R-41-07

BALABAN H. Y., BURUŞ A., ÜÇDAL M., ÇELTİKÇİ B.

FEBS OPEN BIO, Amerika Birleşik Devletleri, 01 Aralık 2025, (Tam Metin Bildiri)

3. THE ROLE OF KILLER IMMUNOGLOBULIN-LIKE RECEPTOR (KIR) GENE VARIANTS IN AUTOIMMUNE HEPATITIS AND PRIMARY BILIARY CHOLANGITIS: ASSOCIATION WITH DISEASE SEVERITY AND DEEP REMISSION

BALABAN H. Y., ÜÇDAL M., BURUŞ A., DAĞ O.

aasld2025, Amerika Birleşik Devletleri, 7 - 11 Kasım 2025, (Tam Metin Bildiri)

4. ROLE OF NUCLEAR RECEPTOR COACTIVATOR 4 (NCOA4) GENE VARIANTS IN METABOLIC HYPERFERRITINEMIA OBSERVED IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH)

BALABAN H. Y., ÜÇDAL M., ŞİMŞEK C., BURUŞ A., ÇELTİKÇİ B.

eug2025, Almanya, 4 - 07 Ekim 2025, (Tam Metin Bildiri)

5. The Cytokine Profile of Primary Biliary Cholangitis (PBC): Is PBC an Autoinflammatory vs. Autoimmune Disease?

RADGOHAR A., ÜÇDAL M. T., BURUŞ A., YALÇINKAYA A., BALABAN H. Y., ÇELTİKÇİ B.

41. Ulusal Gastroenteroloji Haftası, Antalya, Türkiye, 27 Kasım 2024, (Özet Bildiri)

6. Investigation of Apoptosis in Healthy and Inflamed Pulp Tissue

YEKELER A., Bozdemir Ö., BURUŞ A., ZEYBEK N. D., BAYAZIT Y., DOĞAN BUZOĞLU H.

FDI WORLD DENTAL CONGRES, İstanbul, Türkiye, 12 Eylül 2024, cilt.74, (Özet Bildiri)

Diğer Yayınlar 1

1. 46P Effect of coadministration of antioxidant chlorophyllin with docetaxel on invasion and metastasis in triple-negative breast cancer in vivo/in vitro

Buruş A., Özcan M., Canpinar H., Bozdemir Ö., Zeybek N. D.

Sunum, ss.201, 2023 Sürdürülebilir Kalkınma

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

Atıf (Scholar)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler